Universiti Malaya launches RM10mil tropical diseases facility

Star: KUALA LUMPUR: Universiti Malaya’s new RM10mil Modular Biosafety Level 3 (BSL3) Research Facility has been launched, enhancing Malaysia’s ability to combat tropical diseases like the Nipah virus and dengue.
Recognised as the most advanced facility in its class by the French government, the facility was installed by the university’s Tropical Infectious Diseases Research and Education Centre (TIDREC) at the Faculty of Medicine.
Higher Education Minister Datuk Seri Mohamed Khaled Nordin said that with the appropriate biosafety facilities to conduct research on disease samples, the centre is expected to cut local dependence on foreign research labs.
At the same time, collaborative links with local and foreign research institutions could be forged.
Previously, disease samples had to be sent to the Centres for Disease Control and Prevention in Atlanta, United States, for further study.
Mohamed Khaled said that the facility would enhance TIDREC’s role in the study and prevention of infectious tropical diseases.
“We hope that this lab will produce results through the development of vaccines and the commercialisation of research findings,” he said in a press conference.
“I also expect that this facility will also strengthen the country’s national bio-security defences, and help in our measures against biological weapons threats.”
It is learnt that TIDREC is collaborating with researchers from the Defence Ministry. The centre will also develop vaccines and diagnostics to minimise the impact of biological warfare.
The cost of setting up the facility was borne entirely by the ministry.
Also present at the event was French ambassador to Malaysia, Marc Baréty.
Under biocontainment classification, BSL1 labs focus on well-characterised agents not known to consistently cause disease in healthy adult humans while BSL2 facilities cater to pathogens that pose moderate potential hazard to personnel and the environment like hepatitis, dengue fever and influenza A, among others.
BSL3 labs are applicable for indigenous or exotic agents that may cause serious or potentially lethal disease after inhalation like yellow fever and the SARS coronavirus.
Meanwhile, BSL4 facilities are required for work with agents which cause severe to fatal diseases in humans for which vaccines or other treatments are unavailable such as Lassa fever and the Ebola virus.
Mohamed Khaled added that the university’s search for the right person to head its Indian Studies Department was ongoing and a suitable candidate should be identified by June or July.